Genmab A/S (GNMSF)
OTCMKTS · Delayed Price · Currency is USD
285.00
+0.83 (0.29%)
Sep 15, 2025, 12:37 PM EDT
Genmab Market Cap
Genmab has a market cap or net worth of $17.33 billion as of September 17, 2025. Its market cap has decreased by -2.02% in one year.
Market Cap
17.33B
Enterprise Value
14.55B
Revenue
3.65B
Ranking
n/a
PE Ratio
12.64
Stock Price
$285.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 415.12M to 17.33B, an increase of 4,073.49%. That is a compound annual growth rate of 16.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 17.26B | 30.81% |
| Dec 30, 2024 | 13.19B | -36.79% |
| Dec 29, 2023 | 20.88B | -24.42% |
| Dec 30, 2022 | 27.62B | 5.40% |
| Dec 30, 2021 | 26.20B | -1.50% |
| Dec 30, 2020 | 26.60B | 83.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |